Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 6, 2006, Pages

  Yang, Rong Ze ^a   Lee, Mi Jeong ^a   Hu, Hong ^a   Pray, Jessica ^a   Wu, Hai Bin ^a   Hansen, Barbara C ^a   Shuldiner, Alan R ^a,b   Fried, Susan K ^a,b   McLenithan, John C ^a,b   Gong, Da Wei ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Diabetes; Insulin resistance; Metabolic syndrome; Obesity; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; COMPLEMENTARY DNA; INSULIN; LEPTIN; PERILIPIN; PROTEIN OMENTIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DNA LIBRARY; ENERGY METABOLISM; EXPRESSED SEQUENCE TAG; FEMALE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN METABOLISM; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; EXPRESSED SEQUENCE TAGS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INSULIN; LECTINS; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-AKT; STROMAL CELLS;

EID: 33744932403     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00572.2004     Document Type: Article

References (40)

1. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF, and et al. Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252: 1651-1656, 1991.
2. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860-867, 1997.
3. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, and Bluher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54: 2911-2916, 2005.
4. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991.
5. Boguski MS. The turning point in genome research. Trends Biochem Sci 20: 295-296, 1995.
6. Brunzell JD and Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22, Suppl 3: C10-C13, 1999.
7. Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiott KM, Fain JN, and Richelsen B. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 286: E8-E13, 2004.
8. Calabro P, Samudio I, Willerson JT, and Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110: 3335-3340, 2004.
9. Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 30, Suppl 2: S135-S142, 2000.
10. Elbein SC, Hoffman MD, Teng K, Leppert MF, and Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48: 1175-1182, 1999.
11. Francendese A and DeMartinis FD. Very small fat cells. II. Initial observations on basal and hormone-stimulated metabolism. J Lipid Res 26: 149-157, 1985.
12. Fried SK, Lavau M, and Pi-Sunyer FX. Variations of glucose metabolism by fat cells from three adipose depots of the rat. Metabolism 31: 876-883, 1982.
13. Fu M, Gong DW, Damcott C, Sabra M, Yang R, Pollin TI, Tanner K, Ott S, McLenithan JC, Fried S, O'Connell JR, Mitchell BD, and Shuldiner AR. Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the Old Order Amish (Abstract). Diabetes 53: A59, 2004.
14. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, and Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005.
15. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, and Knowler WC. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63: 1130-1138, 1998.
16. Johnson JA, Fried SK, Pi-Sunyer FX, and Albu JB. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Am J Physiol Endocrinol Metab 280: E40-E49, 2001.
17. Kang HY, Cho CL, Huang KL, Wang JC, Hu YC, Lin HK, Chang C, and Huang KE. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res 19: 1181-1190, 2004.
18. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, and Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83: 3925-3929, 1998.
19. Kashiwagi A, Verso MA, Andrews J, Vasquez B, Reaven G, and Foley JE. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 72: 1246-1254, 1983.
20. Kloting N and Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332: 1070-1072, 2005.
21. Klyde BJ and Hirsch J. Isotopic labeling of DNA in rat adipose tissue: evidence for proliferating cells associated with mature adipocytes. J Lipid Res 20: 691-704, 1979.
22. Komiya T, Tanigawa Y, and Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun 251: 759-762, 1998.
23. Kopelman PG. Hormones and obesity. Baillieres Clin Endocrinol Metab 8: 549-575, 1994.
24. Lemieux S. Contribution of visceral obesity to the insulin resistance syndrome. Can J Appl Physiol 26: 273-290, 2001.
25. Lee JK, Schnee J, Pang M, Wolfert M, Baum LG, Moremen KW, and Pierce M. Human homologs of the Xenopus oocyte cortical granule lectin XL35. Glycobiology 11: 65-73, 2001.
26. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, and Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099, 2001.
27. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, and et al. Human obese gene expression Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44: 855-858, 1995.
28. Montague CT, Prins JB, Sanders L, Digby JE, and O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46: 342-347, 1997.
29. Polo R, Verdejo J, Martinez-Rodriguez S, Madrigal P, and Gonzalez-Munoz M. Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients. J Acquir Immune Defic Syndr 25: 284-286, 2000.
30. Russell CD, Petersen RN, Rao SP, Ricci MR, Prasad A, Zhang Y, Brolin RE, and Fried SK. Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am J Physiol Endocrinol Metab 275: E507-E515, 1998.
31. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, Bentolila S, Birren BB, Butler A, Castle AB, Chiannilkulchai N, Chu A, Clee C, Cowles S, Day PJ, Dibling T, Drouot N, Dunham I, Duprat S, East C, Edwards C, Fan JB, Fang N, Fizames C, Garrett C, Green L, Hadley D, Harris M, Harrison P, Brady S, Hicks A, Holloway E, Hui L, Hussain S, Louis-Dit-Sully C, Ma J, MacGilvery A, Mader C, Maratukulam A, Matise TC, McKusick KB, Morissette J, Mungall A, Muselet D, Nusbaum HC, Page DC, Peck A, Perkins S, Piercy M, Qin F, Quackenbush J, Ranby S, Reif T, Rozen S, Sanders C, She X, Silva J, Slonim DK, Soderlund C, Sun WL, Tabar P, Thangarajah T, Vega-Czarny N, Vollrath D, Voyticky S, Wilmer T, Wu X, Adams MD, Auffray C, Walter NA, Brandon R, Dehejia A, Goodfellow PN, Houlgatte R, Hudson JR Jr, Ide SE, Iorio KR, Lee WY, Seki N, Nagase T, Ishikawa N, Nomura N, Phillips C, Polymeropoulos MH, Sandusky M, Schmitt K, Berry R, Swanson K, Torres R, Venter JC, Sikela JM, Beckmann JS, Weissenbach J, Myers RM, Cox DR, James MR, Bentley D, Deloukas P, Lander ES, and Hudson TJ. A gene map of the human genome. Science 274: 540-546, 1996.
32. St Jean P, Husueh WC, Mitchell B, Ehm M, Wanger M, Burns D, and Shuldiner A. Association between diabetes, obesity, glucose andinulin levels in the Old Older Amish and SNPs on 1q21-23. Am J Hum Genet 67: 332, 2000.
33. Suzuki YA, Shin K, and Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 40: 15771-15779, 2001.
34. Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, and Seya T. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 276: 23456-23463, 2001.
35. Van Harmelen V, Lonnqvist F, Thorne A, Wennlund A, Large V, Reynisdottir S, and Arner P. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 21: 972-979, 1997.
36. Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, and Froguel P. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67: 1470-1480, 2000.
37. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O'Rahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, and McCarthy MI. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69: 553-569, 2001.
38. Yang RZ, Blaileanu G, Hansen BC, Shuldiner AR, and Gong DW. cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase. In: Genomics, 2002, p. 445-450.
39. Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin Y, Soukas A, Friedman JM, Holmes WE, and Spiegelman BM. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol 20: 5343-5349, 2000.
40. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, and Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway. Diabetologia 41: 1343-1354, 1998.